Lidoposterin

Lidocaine, the active ingredient in Lidoposterin, is a local anesthetic presented as a topical preparation for cutaneous and rectal use. It provides temporary loss of sensation to relieve pain during minor procedures and discomfort from hemorrhoidal conditions. GNH USA supplies Lidoposterin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lidocaine is a local anesthetic used to provide temporary loss of sensation in specific areas of the body.

Dermatologic procedures: provides local anesthesia for minor skin surgery, biopsies and laser treatments. Hemorrhoidal discomfort: offers topical analgesia for rectal application to ease pain and itching. Dental procedures: numbs oral mucosa to facilitate minor dental work and examinations.

Lidocaine may cause a range of local and systemic reactions, most of which are mild and transient.

Common Side Effects: - Burning or stinging at the application site - Redness or mild erythema - Itching or mild pruritus - Tingling sensation - Local swelling

Serious or Rare Side Effects: - Systemic toxicity presenting as dizziness, tinnitus, seizures or cardiac arrhythmias - Allergic reactions such as urticaria, angioedema or anaphylaxis - Methemoglobinemia, a rare blood disorder causing reduced oxygen delivery - Severe hypotension following extensive absorption - Persistent numbness beyond the expected duration

When using Lidoposterin, several safety measures should be observed to minimise risk. - Assess patient allergy: verify no known hypersensitivity to lidocaine or amide‑type anesthetics. - Limit application area: avoid exceeding the recommended surface area to prevent systemic absorption. - Avoid use on broken skin: apply only to intact mucosa or skin unless directed by a clinician. - Monitor for systemic signs: watch for dizziness, tinnitus, or seizures during and after application. - Store at ambient temperature: keep in the original container, protect from moisture and light.

Lidocaine can interact with other medications, altering its safety profile.

Major Interactions (Avoid): - Class I antiarrhythmics (e.g., quinidine, procainamide) – additive cardiotoxicity. - Beta‑blockers – may enhance central nervous system toxicity. - Strong CYP3A4 inhibitors – increase lidocaine plasma concentrations.

Moderate Interactions (Monitor Closely): - Concurrent use of other local anesthetics – cumulative dose may exceed safe limits. - Epinephrine – can prolong lidocaine effect and affect cardiovascular status. - Diuretics – may modify plasma protein binding, altering free drug levels.